MDS AND AML PRIOR TO ALLOGENEIC SCT

Clinical trials for MDS AND AML PRIOR TO ALLOGENEIC SCT explained in plain language.

Never miss a new study

Get alerted when new MDS AND AML PRIOR TO ALLOGENEIC SCT trials appear

Sign up with your email to follow new studies for MDS AND AML PRIOR TO ALLOGENEIC SCT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Precision proton beam may boost transplant safety for tough blood cancers

Disease control Recruiting now

This study tests a new way to prepare people with high-risk acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) for a stem cell transplant. Instead of standard full-body radiation, participants receive targeted proton radiation to the bone marrow, combined with chemoth…

Matched conditions: MDS AND AML PRIOR TO ALLOGENEIC SCT

Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology and Blood Transfusion, Czech Republic • Aim: Disease control

Last updated May 26, 2026 08:35 UTC

MDS AND AML PRIOR TO ALLOGENEIC SCT

Get alerted when new MDS AND AML PRIOR TO ALLOGENEIC SCT trials appear

Precision proton beam may boost transplant safety for tough blood cancers